AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT02151981 · COMPLETED
Trial details
- NCT number
- NCT02151981
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-04
- Primary completion
- 2016-04-15
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.